Searchable abstracts of presentations at key conferences in endocrinology

ea0065p341 | Nursing practice | SFEBES2019

One-week biochemical investigations in Cushing’s disease – from the endocrine specialist nurse perspective

Serban Laura , Palma August , Hu Lihua , Hale Julia , Tapa Denise , Pitfield Deborah , Senanayake Russell , Bashari Waiel A , Gurnell Mark

Background: Cushing’s disease is the most common cause of endogenous Cushing’s syndrome in adults, affecting females>males (ratio 3:1). In suspected cases, careful clinical assessment is required to ascertain a pre-test probability. This is followed by robust biochemical testing, which guides further management.One-week test protocol: Congruent biochemical tests are conducted over a one-week period in an outpatient setting. Patients attend on d...

ea0063p69 | Calcium and Bone 1 | ECE2019

Pledoary for using Trabecular Bone Score as a method for osteoporosis diagnosis, not only for the risk

Sarbu Adrian , Motoiu Serban , Carsote Mara , Ilie Cosmina , Tocilescu Mihaela , Cristina Staicu Dana , Peretianu Dan , Oprisan Bogdan

Introduction: Trabecular bone score (TBS) was introduced in FRAX, to evaluate more precisely the risk for fracture. However, FRAX is a method for editing a risk, not for making a diagnosis. WHO established conventionally, based on the level of standard deviation (SD), named T score, for Bone Mineral Density (BMD) that <−2,5 SD is compatible with the diagnosis of osteoporosis.Aim: Our aim was to analyze if it is possible to used T score (SD) for...

ea0063p725 | Pituitary and Neuroendocrinology 2 | ECE2019

Remission rate of acromegaly after somatostatin analogs withdrawal: an update

Carosi Giulia , Sala Elisa , Sindaco Giulia Del , Verrua Elisa , Serban Andreea Liliana , Ferrante Emanuele , Arosio Maura , Mantovani Giovanna

Objective: Several studies reported that a long-time therapy with somatostatin analogs (SSTa) in acromegaly could induce persistent remission event after drug withdrawal. The aim of this study was to evaluate GH/IGF-I secretion after SSTa discontinuation in a series of acromegalic patients.Materials and methods: Data of 21 patients regularly referred to our Centre and previously included in a multicentre study, have been updated at the last available fol...

ea0063p790 | Thyroid 2 | ECE2019

The prevalence of macro TSH in patients with subclinical hypothyroidism: experience of a single centre

Serban Andreea , Ferrante Emanuele , Maregnani Alessio , Grassi Giorgia , Mantovani Giovanna , Beck-Peccoz Paolo , Ceriotti Ferruccio , Arosio Maura

Background: Subclinical hypothyroidism (SH) is a frequent clinical condition with a prevalence of 3–15% in general population. It is defined by elevated TSH levels with normal thyroid hormones [free thyroxine (FT4) and free triiodothyronine (FT3)]. Similar to prolactin, high TSH levels may be caused by macroTSH, a large molecular sized TSH with a low bioactivity. The aim of the study was to assess the prevalence of macroTSH in patients with subclinical hypothyroidism....

ea0063p1006 | Environment, Society and Governance | ECE2019

Telemedicine in the management of acromegalic patients

Sindaco Giulia Del , Sala Elisa , Carosi Giulia , Verrua Elisa , Serban Andreea Liliana , Ferrante Emanuele , Arosio Maura , Mantovani Giovanna

Background: In acromegalic patients, quality of life reduction and neuropsychological impairment are common, in addition to well-known complications related to the pituitary adenoma and to the GH/IGF-I excess. Acromegalic patients need a lot of outpatient visits and a multidisciplinary approach during the management of the disease and its comorbidities. Aim of the project is to analyze the role of an electronic health device (eHD) with remote monitoring in management of acrome...

ea0063p1133 | Reproductive Endocrinology 2 | ECE2019

Serum anti-Müllerian hormone is significantly associated with higher luteinizing hormone level in polycystic ovary syndrome

Baculescu Nicoleta , Leonte Laura , Radian Serban , Gheorghiu Monica , Muresan Andrei , Biban Bianca , Baleanu Maria , Grigorescu Florin , Poiana Catalina

Background: Recent data highlight the role of anti-Müllerian hormone (AMH) to trigger the neuroendocrine abnormalities involving GnRH and secretion of gonadotropins in polycystic ovary syndrome (PCOS).Aim: To study factors significantly correlated with neuroendocrine dysfunction in PCOS, with focus on AMH.Subjects and methods: We performed a cross-sectional study in 137 patients with PCOS selected by Rotterdam 2003 criteria an...

ea0049gp137 | Female Reproduction | ECE2017

Genetic susceptibility for adrenal hyperandrogenism in polycystic ovary syndrome

Baculescu Nicoleta , Haydar Sarah , Gheorghiu Monica Livia , Radian Serban , Lautier Corinne , Poiana Catalina , Pugeat Michel , Grigorescu Florin

Background: Hyperandrogenism is a main feature of the polycystic ovary syndrome (PCOS). Although its ovarian origin is well recognized, laboratory investigation suggested the contribution of adrenal gland, albeit of unknown mechanism.Aim: To understand the contribution of genetic factors in adrenal hyperandrogenism (AH) we investigated genome wide SNPs in subgroups of PCOS patients stratified as function of DHEAS levels in two ethnic populations (Romania...

ea0049ep809 | Obesity | ECE2017

Obesity, gonadotropic axis and breast cancer – is ghrelin the connexion?

Armasu Ioana , Crumpei Iulia , Volovat Constantin , Tofan Mariana , Zaharia Valentin , Aancutei Adrian , Vasiliu Ioana , Lacramioara Serban Ionela , Vulpoi Carmen

Introduction: Obesity and insulin resistance have been identified as risk factors for breast cancer and are associated with late-stage diagnosis and poor prognosis. Ghrelin is a unique gut-derived peptide that has major impact in energy homeostasis and weight regulation, with new emerging implications in tumorigenesis process, especially in hormone-dependent cancers.Aim: To evaluate the relationship between ghrelin, clinico-biological parameters of obesi...

ea0059oc4.6 | Clinical highlights | SFEBES2018

11C-Methionine PET/MRI is superior to MRI for localisation of functioning prolactinomas and may facilitate targeted intervention

Bashari Waiel , Powlson Andrew , Senanayake Russell , Sekaran Arvindh , Serban Laura , Koulouri Olympia , Gillet Daniel , Cheow Heok , Mendichovszky Iosif , Gurnell Mark

Background: Prolactinomas are the commonest hormone-secreting pituitary adenomas. First-line treatment is dopamine agonist (DA) therapy. However, side-effects are increasingly recognised, leading to an increasing consideration of transsphenoidal surgery (TSS) and/or radiotherapy. Co-registration of 11C-methionine Positron Emission Tomography (Met-PET) imaging with Spoiled Gradient Recalled Acquisition MRI (SPGR MRI), referred to in combination as Met-PET/MRI, can aid accurate ...

ea0059ep14 | Adrenal and steroids | SFEBES2018

Cushing’s syndrome due to primary bilateral macronodular adrenal hyperplasia (PBMAH) - clinical and hormonal characterisation

Vladan Andreea , Radian Serban , Baranga Iuliana , Moraru Catalina , Deciu Diana , Dumitrascu Anda , Hortopan Dan , Iorgulescu Radu , Poiana Catalina

Background: PBMAH is a rare cause of adrenal Cushing’s syndrome, frequently due to aberrant adrenal expression of hormonal receptors.Aim: To describe 6 patients with PBMAH.Methods: Clinical, hormonal and imagistic evaluation.Results: Age at diagnosis of patients (4M/2F) was 50–79 years. One asymptomatic patient was incidentally diagnosed on abdominal CT, two patients had overt Cushing’s (centra...